FDA Import Refusal AEK-7248433-8/12/1 — Napp Pharmaceuticals
The FDA refused shipment AEK-7248433-8/12/1 from Napp Pharmaceuticals (United Kingdom) on Jul 11, 2025. The refused product falls under Drugs and Biologics — DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Jul 11, 2025
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 62OCY24 DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75